Sophia Genetics and MSK join forces to develop precision oncology hub

The entities intend for their latest pair-up to progress new approaches to multimodal precision oncology. The entities intend for their latest pair-up to progress new approaches to multimodal precision oncology. According to Sophia Genetics, previous collaborations with MSK have brought MSK diagnostics to hospitals, labs, and patients in 35 countries via its SOPHiA data-driven medicine (DDM) platform. Credit: CI Photos / Shutterstock.com SOPHiA GENETICS and Memorial Sloan Kettering Cancer Center (MSK) have signed a memorandum of understanding (MoU) that will set in motion plans for the entities to combine their respective expertise to create a precision medicine hub to advance…

Source: Medical Device Network